(Tiper Stock Exchange) – The alert of the World Health Organization is triggered for some syrups against cough, cold and fluwhich they would cause serious damage to health in children.
These drugs, produced by the Indian company Marion BiotechI am distributed in Europe via Uzbekistan, but may also have been distributed informally in other countries or regions. The case came to light after the analyzes conducted by the Uzbek authorities following the death of about twenty children.
The WHO alert concerns the syrup Ambronol and the drug marketed under the brand name Dok-1 Maxaccused of containing unacceptable amounts of diethylene glycol or ethylene glycol as contaminants, two molecules considered toxic to humanswhich could result in serious injury or even death. Symptoms also include abdominal pain, vomiting, diarrhea, inability to urinate, headache, altered mental status, and acute kidney damage.
Marion Biotech is the second Indian producer to be investigated by the WHO since October, after the case of Maiden Pharmaceuticals, who underwent the same treatment for marketing cold and cough medicines responsible for the death of 66 children in The Gambia.
WHO has called on the supervisory authorities of each country to increase internal surveillance to monitor the possible presence on the market of the products.
The cough syrup market promises well in the medium term. Over the next 4 or 5 years one is expected average annual growth of 3-4% (CAGR) after the boom of the “Covid period” (years 2020 and 2021) when the consumption of syrups literally skyrocketed.